We are live on
!
Find out more
RHBC
R.H. Bluestein & Co Portfolio holdings
AUM
$1.61B
1-Year Est. Return
7.59%
This Fund
S&P 500
This Quarter
Est. Return
+8.82%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
–
AUM
$1.67B
AUM Growth
+$135M
(+8.8%)
Cap. Flow
+$22.1M
Cap. Flow
% of AUM
1.32%
Top 10 Holdings %
Top 10 Hldgs %
32.92%
Holding
336
New
30
Increased
77
Reduced
81
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$18.9M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$17M |
| 3 |
Aptiv
APTV
|
+$15.8M |
| 4 |
Intel
INTC
|
+$13.5M |
| 5 |
Salesforce
CRM
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$27.3M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$24.2M |
| 3 |
Palo Alto Networks
PANW
|
+$23.4M |
| 4 |
ExxonMobil
XOM
|
+$17.1M |
| 5 |
Caterpillar
CAT
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.82% |
| 2 | Communication Services | 14.56% |
| 3 | Healthcare | 11.18% |
| 4 | Technology | 10.25% |
| 5 | Consumer Discretionary | 9.96% |
Similar funds
BDF
ACM
SCA
WFA
IC
CA
RIG
CCP
R.H. Bluestein & Co's Q1 2017 Portfolio in Review
As of Q1 2017, R.H. Bluestein & Co held 336 positions worth $1.67B, up 8.8% from $1.53B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
R.H. Bluestein & Co's Q1 2017 filing shows 30 new, 77 increased, 81 reduced and 11 closed positions. Its largest new stake was SunTrust Banks, Inc.: 296,401 shares worth $16.4M. The largest sale was Monsanto Co, an estimated $27.3M.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Communication Services and Healthcare.
- R.H. Bluestein & Co's largest Q1 2017 buy was SunTrust Banks, Inc.: 296,401 shares worth $16.4M.
- R.H. Bluestein & Co added most to Microsoft in Q1 2017, an estimated $18.9M increase.
- R.H. Bluestein & Co's biggest Q1 2017 reduction was Monsanto Co, cutting an estimated $27.3M.
- R.H. Bluestein & Co fully exited Bristol-Myers Squibb in Q1 2017, selling an estimated $24.2M.
- R.H. Bluestein & Co's ten largest holdings make up 33% of its $1.67B portfolio in Q1 2017.
- R.H. Bluestein & Co opened 30 new positions and closed 11 in Q1 2017.
- R.H. Bluestein & Co's portfolio value rose 8.8% quarter-over-quarter to $1.67B.
Based on R.H. Bluestein & Co's 13F filing for Q1 2017, filed 12 May 2017.